Pradžia › Parkinsono liga › Washington
Parkinsono liga klinikiniai tyrimai Washington
15 tyrimai dėl Parkinsono liga ieško dalyvių vietose Washington.
Miestai Washington
Oficialus tyrimo tekstas (anglų kalba)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
Renkami dalyviai2/3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06976268A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
Renkami dalyviai2/3 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
Renkami dalyviai2 fazė
Amžius nuo 30 iki 80 · Visoms lytims · Atnaujinta 2026-09-10 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 45 iki 75 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07330258A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
Renkami dalyviai3 fazė
Amžius nuo 45 iki 75 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Renkami dalyviai
Amžius nuo 21 iki 80 · Visoms lytims · Atnaujinta 2026-05-28 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 30 iki 85 · Visoms lytims · Atnaujinta 2026-04-20 · NCT06809400The Parkinson's Genetic Research Study
- VA Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-05-14 · NCT01558479Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
Renkami dalyviaiStebimasis tyrimas
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2022-03-25 · NCT02194816Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.